Funded Tech Companies
Allakos
Allakos, operating out of Redwood City, received equity investments from Roche Venture Fund, Partner Fund Management and 3x5 Special Opportunity Partners.
Company Overview
Company Name
Allakos
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
975 Island Dr. 201
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Website
Email Address
Company Background Information
Overview
Allakos (Nasdaq: ALLK) is a biotechnology company developing antibodies targeting receptors that modulate the activity of immune effector cells involved in inflammation and tissue damage.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/18/2018
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Alexander
Chief Medical Officer
Henrik Rasmussen
Chief Operating Officer
Adam Tomasi
VP - Bus. Development
Simon Greenwood
VP - General Counsel
Mark Asbury
VP - Regulatory Affairs
Sally Bolmer
Company Investors
- Roche Venture Fund
- Partner Fund Management
- 3x5 Special Opportunity Partners
- New Enterprise Associates (Paul Walker)
- Rock Springs Capital
- Samsara BioCapital
- RiverVest Venture Partners (John McKearn)
- LifeSci Venture Partners
- Alta Partners (Robert Alexander)
- Redmile Group
- Novo Ventures (Peter Moldt)
Browse more funded tech companies:
Alladapt Immunotherapeutics | Allara
Share this article
About Our VC Transaction Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs